|
Volumn 53, Issue 3, 2011, Pages 1060-1061
|
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the american association for the study of liver diseases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA FETOPROTEIN;
CANCER RISK;
CLINICAL PRACTICE;
DISEASE CARRIER;
DISEASE SURVEILLANCE;
DRUG EFFICACY;
HEPATITIS B;
HEPATITIS C;
HUMAN;
LETTER;
LIVER CELL CARCINOMA;
LIVER DISEASE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SENSITIVITY AND SPECIFICITY;
UNITED STATES;
ALPHA-FETOPROTEINS;
CARCINOMA, HEPATOCELLULAR;
HEPATITIS C;
HUMANS;
LIVER NEOPLASMS;
POPULATION SURVEILLANCE;
PRACTICE GUIDELINES AS TOPIC;
|
EID: 79952230973
PISSN: 02709139
EISSN: 15273350
Source Type: Journal
DOI: 10.1002/hep.24033 Document Type: Letter |
Times cited : (59)
|
References (8)
|